Nadav Kidron Oramed Pharmaceuticals Inc. (ORMP) insider trading activity

Nadav Kidron is President and CEO of ORAMED PHARMACEUTICALS INC.. Currently has a direct ownership of 2.26 Million shares of ORMP, which is worth approximately $5.24 Million. The most recent transaction as insider was on Jan 02, 2025, when has been sold 433,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.26M

26.87% 3M change

26.87% 12M change

Total Value Held $5.24 Million

NADAV KIDRON Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 02 2025	BUY Grant, award, or other acquisition	-	433,500 Added 16.1%	2,259,598 Common Stock
Nov 07 2024	BUY Grant, award, or other acquisition	-	45,000 Added 2.41%	1,826,098 Common Stock
Jan 04 2024	BUY Grant, award, or other acquisition	-	329,000 Added 15.59%	1,781,098 Common Stock
May 26 2023	BUY Grant, award, or other acquisition	-	120,000 Added 7.63%	1,452,098 Common Stock
Apr 17 2023	BUY Grant, award, or other acquisition	-	279,000 Added 17.32%	1,332,098 Common Stock
Oct 27 2022	SELL Bona fide gift	-	25,000 Reduced 2.32%	1,053,098 Common Stock
Aug 01 2022	SELL Payment of exercise price or tax liability	$105,595 $8.36 p/Share	12,631 Reduced 1.16%	1,078,098 Common Stock
Jul 28 2022	BUY Grant, award, or other acquisition	-	160,000 Added 12.79%	1,090,729 Common Stock
Jan 03 2022	SELL Payment of exercise price or tax liability	$677,165 $13.89 p/Share	48,752 Reduced 5.21%	887,729 Common Stock
Jan 03 2022	BUY Grant, award, or other acquisition	-	213,000 Added 18.3%	950,729 Common Stock
Dec 30 2021	SELL Bona fide gift	-	20,000 Reduced 2.54%	766,481 Common Stock
Dec 28 2021	SELL Payment of exercise price or tax liability	$411,829 $12.98 p/Share	31,728 Reduced 3.88%	786,481 Common Stock
Dec 03 2021	SELL Bona fide gift	-	20,000 Reduced 2.39%	818,209 Common Stock
Aug 31 2021	BUY Grant, award, or other acquisition	-	100,000 Added 11.78%	748,573 Common Stock
Aug 09 2021	SELL Open market or private sale	$4,424,200 $20.11 p/Share	220,000 Reduced 25.33%	648,573 Common Stock

Nadav Kidron

President and CEO

New York, NY

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ORMP shares.

Notify only if

Value

Insider Trading

Get notified when an Oramed Pharmaceuticals Inc. insider buys or sells ORMP shares.

Notify only if

Operation

Value

Type

News

Receive news related to ORAMED PHARMACEUTICALS INC.

Track Activities on ORMP

Account